The DOI matches its Crossref record; 86 of the 86 references it cites were found in a registry or an index.
Spatial correlation between brain aerobic glycolysis and amyloid-β (Aβ) deposition
Open accessAbstract
Amyloid-β (Aβ) plaque deposition can precede the clinical manifestations of dementia of the Alzheimer type (DAT) by many years and can be associated with changes in brain metabolism. Both the Aβ plaque deposition and the changes in metabolism appear to be concentrated in the brain's default-mode network. In contrast to prior studies of brain metabolism which viewed brain metabolism from a unitary perspective that equated glucose utilization with oxygen consumption, we here report on regional glucose use apart from that entering oxidative phosphorylation (so-called "aerobic glycolysis"). Using PET, we found that the spatial distribution of aerobic glycolysis in normal young adults correlates spatially with Aβ deposition in individuals with DAT and cognitively normal participants with elevated Aβ, suggesting a possible link between regional aerobic glycolysis in young adulthood and later development of Alzheimer pathology.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Similarly, brain AG was previously found to be highest in regions most vulnerable to amyloid deposition”
From Aerobic glycolysis in the human brain is associated with development and neotenous gene expression (2014) · cites this paper as Vlassenko et al., 2010
In the citing paper
“Further, AG identifies regions most vulnerable to amyloid-beta deposition in Alzheimer’s disease”
From Aerobic glycolysis in the human brain is associated with development and neotenous gene expression (2014) · cites this paper as Vlassenko et al., 2010
In the citing paper
“Young ApoE4 carriers showed increased brain activity in default network regions, as well as in the hippocampus and the temporal lobe, possibly due to increased aerobic glycolysis.34”
From ApoE4-dependent lysosomal cholesterol accumulation impairs mitochondrial homeostasis and oxidative phosphorylation in human astrocytes (2023) · cites this paper as [34]
In the citing paper
“Whether Aβ changes precede either age-related or AD-related brain bioenergetic changes is less clear-cut, especially since abundant data from human and cell-based studies either suggest or demonstrate bioenergetic factors regulate both APP processing and Aβ production [95–100].”
From Brain aging, Alzheimer's disease, and mitochondria (2011) · cites this paper as [99]
In the citing paper
“Whether Aβ changes precede either age-related or AD-related brain bioenergetic changes is less clear-cut, especially since abundant data from human and cell-based studies either suggest or demonstrate bioenergetic factors regulate both APP processing and Aβ production [95–100].”
From Brain aging, Alzheimer's disease, and mitochondria (2011) · cites this paper as [99]
In the citing paper
“Brain plaque deposition anatomically corresponds to the functional magnetic resonance imaging (fMRI)-defined default mode network (DMN), a brain region characterized by relatively high glycolysis rates [69, 99, 136].”
From Brain aging, Alzheimer's disease, and mitochondria (2011) · cites this paper as [99]
In the citing paper
“Bioenergetic metabolism certainly affects APP processing and Aβ production.”
From Brain aging, Alzheimer's disease, and mitochondria (2011) · cites this paper as [99]
Citations
Cites
Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
Vander Heiden, M. G., Cantley, L. C., & Thompson, C. B. (2009) · Science · doi:10.1126/science.1160809 · Cited by 16,197
The Amyloid Hypothesis of Alzheimer’s Disease: Progress and Problems on the Road to Therapeutics
Hardy, J., & Selkoe, D. J. (2002) · Science · doi:10.1126/science.1072994 · Cited by 13,864
A default mode of brain function
Raichle, M. E., MacLeod, A. M., Snyder, A. Z., Powers, W. J., Gusnard, D. A., & Shulman, G. L. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.98.2.676 · Cited by 12,190
Self-citationThe Clinical Dementia Rating (CDR): Current version and scoring rules
Morris, J. C. (1993) · Neurology · doi:10.1212/wnl.43.11.2412-a · Cited by 9,882
Self-citationThe Brain's Default Network: Anatomy, Function, and Relevance to Disease
Buckner, R. L., Andrews‐Hanna, J. R., & Schacter, D. L. (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1440.011 · Cited by 9,761
Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound‐B
Klunk, W. E., Engler, H., Nordberg, A., Wang, Y., Blomqvist, G., Holt, D. P., Bergström, M., Savitcheva, I., Huang, G., Estrada, S., et al. (2004) · Annals of Neurology · doi:10.1002/ana.20009 · Cited by 4,496
Pathways towards and Away from Alzheimer’s Disease
Mattson, M. P. (2004) · Nature · doi:10.1038/nature02621 · Cited by 3,052
Pellerin, L., & Magistretti, P. J. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.22.10625 · Cited by 2,927 · cited 1×
“First, it is essential for the removal of glutamate into astrocytes from the synaptic cleft (40).”
BackgroundPhelps, M. E., Huang, S. C., Hoffman, E. J., Selin, C. E., Sokoloff, L., & Kuhl, D. E. (1979) · Annals of Neurology · doi:10.1002/ana.410060502 · Cited by 2,417
A default mode of brain function: a brief history of an evolving idea
Raichle, M. E., & Snyder, A. Z. (2007) · NeuroImage · doi:10.1016/j.neuroimage.2007.02.041 · Cited by 2,173
Self-citation
Cited by
Sorted by citations
Items 201–300 of 405
Neuronal culture microenvironments determine preferences in bioenergetic pathway use
Sünwoldt, J., Bosche, B., Meisel, A., & Mergenthaler, P. (2017) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2017.00305 · Cited by 34
Hartl, D., Schuldt, V., Forler, S., Zabel, C., Klose, J., & Rohe, M. (2012) · Journal of Proteome Research · doi:10.1021/pr300021e · Cited by 48
Han, S., He, Z., Hu, X., Li, X., Zheng, K., Huang, Y., Xiao, P., Xie, Q., Ni, J., & Liu, Q. (2023) · Antioxidants · doi:10.3390/antiox12030722 · Cited by 34
Jassim, A. H., Coughlin, L., Harun‐Or‐Rashid, M., Kang, P. T., Chen, Y., & Inman, D. M. (2019) · Molecular Neurobiology · doi:10.1007/s12035-019-1576-4 · Cited by 34
Powell, C. L., Davidson, A. R., & Brown, A. M. (2020) · Biosensors · doi:10.3390/bios10110183 · Cited by 33
Carroll, C. M., & Macauley, S. L. (2019) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2019.00258 · Cited by 32
What is bipolar disorder? A disease model of dysregulated energy expenditure
Mansur, R. B., Lee, Y. L., McIntyre, R. S., & Brietzke, E. M. (2020) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2020.04.006 · Cited by 33
Trans-Synaptic Spread of Amyloid-βin Alzheimer’s Disease: Paths toβ-Amyloidosis
Pignataro, A., & Middei, S. (2017) · Neural Plasticity · doi:10.1155/2017/5281829 · Cited by 34
Anazodo, U., Thiessen, J. D., Ssali, T., Mandel, J., nther, M. G. ⁄., Butler, J., Pavlosky, W. F., Prato, F. S., Thompson, R. T., & Lawrence, K. S. (2015) · Frontiers in Neuroscience · doi:10.3389/fnins.2014.00434 · Cited by 31
Multimodal Imaging of Alzheimer Pathophysiology in the Brain′s Default Mode Network
Shin, J., Kepe, V., Small, G. W., Phelps, M. E., & Barrio, J. R. (2011) · International Journal of Alzheimer s Disease · doi:10.4061/2011/687945 · Cited by 32
Grizzanti, J., Moritz, W. R., Pait, M. C., Stanley, M., Kaye, S. D., Carroll, C. M., Constantino, N. J., Deitelzweig, L. J., Snipes, J. A., Kellar, D., et al. (2023) · JCI Insight · doi:10.1172/jci.insight.162454 · Cited by 32
The energetic basis of behavior: bridging behavioral ecology and neuroscience
Rittschof, C. C., Grozinger, C. M., & Robinson, G. E. (2015) · Current Opinion in Behavioral Sciences · doi:10.1016/j.cobeha.2015.07.006 · Cited by 28
Vlassenko, A. G., McConathy, J., Couture, L. E., Su, Y., Massoumzadeh, P., Leeds, H., Chicoine, M. R., Tran, D. D., Huang, J., Dahiya, S. M., et al. (2015) · Disease Markers · doi:10.1155/2015/874904 · Cited by 29
Self-citationLin, W., Liu, Y., Molho, M., Zhang, S., Wang, L., Xie, L., & Nagy, P. D. (2019) · PLoS Pathogens · doi:10.1371/journal.ppat.1008092 · Cited by 30
Kikuchi, M., Hirosawa, T., Yokokura, M., Yagi, S., Mori, N., Yoshikawa, E., Yoshihara, Y., Sugihara, G., Takebayashi, K., Iwata, Y., et al. (2011) · Journal of Neuroscience · doi:10.1523/jneurosci.2535-11.2011 · Cited by 31
Jayasena, T., Poljak, A., Braidy, N., Smythe, G., Raftery, M., Hill, M., Brodaty, H., Trollor, J., Kochan, N., & Sachdev, P. (2015) · PLOS ONE · doi:10.1371/journal.pone.0116092 · Cited by 30
Rojas-Pirela, M., Andrade-Alviárez, D., Rojas, V., Marcos, M., Salete-Granado, D., Chacón-Arnaude, M., Pérez-Nieto, M. Á., Kemmerling, U., Concepción, J. L., Michels, P. A. M., et al. (2025) · Open Biology · doi:10.1098/rsob.240239 · Cited by 31
Jett, S., Dyke, J. P., Andy, C., Schelbaum, E., Jang, G., Boneu, C., Pahlajani, S. S., Diaz, I., Brinton, R. D., & Mosconi, L. (2022) · Scientific Reports · doi:10.1038/s41598-022-26573-5 · Cited by 29
Ourry, V., Binette, A. P., St‐Onge, F., Strikwerda‐Brown, C., Chagnot, A., Poirier, J., Breitner, J. C. S., Arenaza‐Urquijo, E. M., Rabin, J. S., Buckley, R. F., et al. (2023) · Biological Psychiatry · doi:10.1016/j.biopsych.2023.09.003 · Cited by 30
Age-dependent effect of Alzheimer’s risk variant of CLU on EEG alpha rhythm in non-demented adults
Пономарева, Н. В., Андреева, Т. В., Protasova, M., Shagam, L., Malina, D. D., Goltsov, A., Fokin, V. F., Алексеевич, М. А., & Rogaev, E. I. (2013) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2013.00086 · Cited by 29
„Default-mode“-Netzwerk des Gehirns
Otti, A., Gündel, H., Wohlschläger, A., Zimmer, C., Sorg, C., & Noll‐Hussong, M. (2011) · Der Nervenarzt · doi:10.1007/s00115-011-3307-6 · Cited by 30
Yotter, R. A., Doshi, J. J., Clark, V., Sojkova, J., Zhou, Y., Wong, D. F., Ferrucci, L., Resnick, S. M., & Davatzikos, C. A. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.05.030 · Cited by 29
Comparison of Amyloid β and Tau Spread Models in Alzheimer’s Disease
Kim, H., Lee, P., Seo, S. W., Roh, J. H., Oh, M., Oh, J. S., Oh, S. J., Kim, J. S., & Jeong, Y. (2018) · Cerebral Cortex · doi:10.1093/cercor/bhy311 · Cited by 32
Role of astrocytic glycolytic metabolism in Alzheimer’s disease pathogenesis
Fu, W., & Jhamandas, J. H. (2014) · Biogerontology · doi:10.1007/s10522-014-9525-0 · Cited by 28
Alavi, A. A., Barrio, J. R., Werner, T. J., Khosravi, M., Newberg, A. B., & Høilund‐Carlsen, P. F. (2019) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-019-04564-5 · Cited by 28
Martini, A. C., Gross, T. J., Head, E., & Mapstone, M. E. (2022) · Neuron · doi:10.1016/j.neuron.2022.04.001 · Cited by 26
Su, Y., Vlassenko, A. G., Couture, L. E., Benzinger, T. L. S., Snyder, A. Z., Derdeyn, C. P., & Raichle, M. E. (2016) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x16656200 · Cited by 27
Self-citationCrocco, P., Saiardi, A., Wilson, M., Maletta, R., Bruni, A. C., Passarino, G., & Rose, G. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2016.06.014 · Cited by 29
Bell, S., Marco, M. D., Barnes, K., Shaw, P. J., Ferraiuolo, L., Blackburn, D. J., Mortiboys, H., & Venneri, A. (2020) · Journal of Personalized Medicine · doi:10.3390/jpm10020032 · Cited by 30
The Effects of Amyloid and Tau on Functional Network Connectivity in Older Populations
Wales, R. M., & Leung, H.-C. (2021) · Brain Connectivity · doi:10.1089/brain.2020.0902 · Cited by 26
The controllosphere: The neural origin of cognitive effort.
Holroyd, C. B. (2024) · Psychological Review · doi:10.1037/rev0000467 · Cited by 33
The Energetic Collapse of the Alzheimer's Brain: Metabolic Inflexibility Across Cells and Networks
Constantino, N. J., Ashley, C. C., & Macauley, S. L. (2025) · Journal of Neurochemistry · doi:10.1111/jnc.70294 · Cited by 29
Functional integrity in children with anoxic brain injury from drowning
Ishaque, M., Manning, J. H., Woolsey, M. D., Franklin, C. G., Tullis, E. W., Beckmann, C. F., & Fox, P. T. (2017) · Human Brain Mapping · doi:10.1002/hbm.23745 · Cited by 27
Astrocytic transporters in Alzheimer's disease
Ugbode, C., Hu, Y., Whalley, B., Peers, C., Rattray, M., & Dallas, M. L. (2017) · Biochemical Journal · doi:10.1042/bcj20160505 · Cited by 25
Choi, Y., Kang, S., Ko, S.-Y., Lee, S., Kim, J. Y., Lee, H., Song, J. E., Kim, D., Kim, E., Kim, C. H., et al. (2018) · Molecular Brain · doi:10.1186/s13041-018-0415-2 · Cited by 27
Impact of Genetic Risk Factors for Alzheimer’s Disease on Brain Glucose Metabolism
Cho, S., Lee, H., & Seo, J. (2021) · Molecular Neurobiology · doi:10.1007/s12035-021-02297-x · Cited by 25
Shinohara, M., Koga, S., Konno, T., Nix, J., Shinohara, M., Aoki, N., Das, P., Parisi, J. E., Petersen, R. C., Rosenberry, T. L., et al. (2017) · Brain · doi:10.1093/brain/awx284 · Cited by 24
A quantitative model of human neurodegenerative diseases involving protein aggregation
Kepp, K. P. (2019) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2019.04.001 · Cited by 23
Westi, E. W., Andersen, J. V., & Aldana, B. I. (2023) · Neurobiology of Disease · doi:10.1016/j.nbd.2023.106145 · Cited by 23
Boccardi, V., Pigliautile, M., Guazzarini, A. G., & Mecocci, P. (2023) · Biomolecules · doi:10.3390/biom13071133 · Cited by 26
Ghosh, R., Sil, S., Gupta, P., & Ghosh, T. (2020) · Metabolic Brain Disease · doi:10.1007/s11011-020-00588-1 · Cited by 24
Ketotherapeutics for neurodegenerative diseases
Norwitz, N. G., Gilbert‐Jaramillo, J., Clarke, K., & Soto-Mota, A. (2020) · International review of neurobiology · doi:10.1016/bs.irn.2020.02.003 · Cited by 24
Pandya, S., Initiative, A. D. N., Kuceyeski, A. F., & Raj, A. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-160090 · Cited by 24
5‐Methoxyindole‐2‐carboxylic acid (MICA) suppresses A&bgr;‐mediated pathology in C. elegans
Ahmad, W., & Ebert, P. (2018) · Experimental Gerontology · doi:10.1016/j.exger.2018.04.021 · Cited by 19
Mozersky, J. T., Hartz, S. M., Linnenbringer, E. L., Levin, L., Streitz, M. L., Stock, K., Moulder, K. L., & Morris, J. C. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-200993 · Cited by 24
Self-citationBACE1 activity impairs neuronal glucose oxidation: rescue by beta-hydroxybutyrate and lipoic acid
Findlay, J. A., Hamilton, D. L., & Ashford, M. L. J. (2015) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2015.00382 · Cited by 22
Chen, Y., Lin, Q., Liao, X., Zhou, C., & Yong He, A. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2013232118 · Cited by 22
A quantitative neural network approach to understanding aging phenotypes
Ash, J. A., & Rapp, P. R. (2014) · Ageing Research Reviews · doi:10.1016/j.arr.2014.02.001 · Cited by 20
Iguchi, S., Moriguchi, T., Yamazaki, M., Hori, Y., Koshino, K., Toyoda, Ḱ., Teuho, J., Shimochi, S., Terakawa, Y., Fukuda, T., et al. (2018) · EJNMMI Physics · doi:10.1186/s40658-018-0236-5 · Cited by 21
β-amyloid monomers drive up neuronal aerobic glycolysis in response to energy stressors
Santangelo, R., Giuffrida, M. L., Satriano, C., Tomasello, M. F., Zimbone, S., & Copani, A. (2021) · Aging · doi:10.18632/aging.203330 · Cited by 21
Neill, D. (2011) · Ageing Research Reviews · doi:10.1016/j.arr.2011.06.004 · Cited by 22
Hypoperfusion is a potential inducer of immunosuppressive network in Alzheimer's disease
Salminen, A. (2020) · Neurochemistry International · doi:10.1016/j.neuint.2020.104919 · Cited by 20
Synaptic Plasticity and the Warburg Effect
Magistretti, P. J. (2014) · Cell Metabolism · doi:10.1016/j.cmet.2013.12.012 · Cited by 20
Lin, C., Ly, M., Karim, H. T., Wei, W., Snitz, B. E., Klunk, W. E., & Aizenstein, H. J. (2020) · Alzheimer's Research & Therapy · doi:10.1186/s13195-019-0573-1 · Cited by 19
Wu, Y., Yang, L., Jiang, W., Zhang, X., & Yao, Z. (2024) · Neural Regeneration Research · doi:10.4103/nrr.nrr-d-24-00190 · Cited by 19
L-Lactate Administration Improved Synaptic Plasticity and Cognition in Early 3xTg-AD Mice
Wang, Y., Zhao, J., & Zhao, L. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26041486 · Cited by 19
Tsvetanov, K. A., Spindler, L. R. B., Stamatakis, E. A., Newcombe, V., Lupson, V. C., Chatfield, D. A., Manktelow, A. E., Outtrim, J. G., Elmer, A., Kingston, N., et al. (2022) · NeuroImage Clinical · doi:10.1016/j.nicl.2022.103253 · Cited by 20
Khan, A. S., Peterson, K. A., Vittay, O. I., McLean, M. A., Kaggie, J. D., O'Brien, J. T., Rowe, J. B., Gallagher, F. A., & Matys, T. (2024) · Radiology · doi:10.1148/radiol.232407 · Cited by 19
The Relationship between Amyloid Deposition, Neurodegeneration, and Cognitive Decline in Dementia
Vandenberghe, R. R. (2014) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-014-0498-9 · Cited by 21
Shen, L., Han, B., Geng, Y., Wang, J., Wang, Z., & Wang, M. (2017) · PLoS ONE · doi:10.1371/journal.pone.0174763 · Cited by 19
Li, J., Zhang, B., Jia, W., Yang, M., Zhang, Y., Zhang, J., Li, L., Jin, T., Wang, Z., Tao, J., et al. (2021) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2021.774569 · Cited by 19
Dong, C., Liu, T., Wen, W., Kochan, N. A., Jiang, J., Li, Q., Liu, H., Niu, H., Zhang, W., Wang, Y., et al. (2018) · Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring · doi:10.1016/j.dadm.2018.08.011 · Cited by 18
Hypoxia/ischemia impairs CD33 (Siglec-3)/TREM2 signaling: Potential role in Alzheimer's pathogenesis
Salminen, A., Kaarniranta, K., & Kauppinen, A. (2021) · Neurochemistry International · doi:10.1016/j.neuint.2021.105186 · Cited by 20
Brain Energy Metabolism in Health and Disease
Felipe, A., Anbal, I., Paz, M., & Maite, A. (2012) · InTech eBooks · doi:10.5772/36092 · Cited by 18
Ye, Y., Chai, S.-F., Li, X.-R., Wu, M., Cai, H.-Y., & Wang, Z.-J. (2023) · Metabolic Brain Disease · doi:10.1007/s11011-023-01288-2 · Cited by 18
Quantitative Analysis of the Effective Functional Structure in Yeast Glycolysis
la Fuente, I. M. D., & Cortés, J. M. (2012) · PLoS ONE · doi:10.1371/journal.pone.0030162 · Cited by 19
Mechanisms underlying pathological cortical bursts during metabolic depletion
Dutta, S., Iyer, K. K., Vanhatalo, S., Breakspear, M. J., & Roberts, J. A. (2023) · Nature Communications · doi:10.1038/s41467-023-40437-0 · Cited by 16
Shin, J., Tsui, W., Li, Y., Lee, S., Kim, S. J., Cho, S., Kim, Y.-B., & de Leon, M. J. (2011) · International Journal of Alzheimer s Disease · doi:10.4061/2011/759780 · Cited by 16
Goyal, M. S., Gordon, B. A., Couture, L. E., Flores, S. E., Xiong, C., Morris, J. C., Raichle, M. E., Benzinger, T. L. S., & Vlassenko, A. G. (2020) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2020.08.019 · Cited by 16
Self-citationRates of β-amyloid deposition indicate widespread simultaneous accumulation throughout the brain
LaPoint, M. R., Baker, S. L., Landau, S. M., Harrison, T. M., & Jagust, W. J. (2022) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2022.03.005 · Cited by 18
Pharmacologic enrichment of exosome yields and mitochondrial cargo
Wang, X., Berkowicz, A., King, K., Menta, B. W., Gabrielli, A. P., Novikova, L., Troutwine, B., Pleen, J., Wilkins, H., & Swerdlow, R. H. (2022) · Mitochondrion · doi:10.1016/j.mito.2022.04.001 · Cited by 16
Low Residual CBF Variability in Alzheimer’s Disease after Correction for CO2 Effect
Rodell, A. B., Aanerud, J., Brændgaard, H., & GJEDDE, A. H. (2012) · Frontiers in Neuroenergetics · doi:10.3389/fnene.2012.00008 · Cited by 15
Neuroimaging Biomarkers of Caloric Restriction on Brain Metabolic and Vascular Functions
Lin, A., Parikh, I. J., Hoffman, J. D., & Ma, D. (2017) · Current Nutrition Reports · doi:10.1007/s13668-017-0187-9 · Cited by 16
Qiu, Z., Bai, X., Ji, X., Wang, X., Han, X., Wang, D., Jiang, F., & An, Y. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.960906 · Cited by 15
Villar, G. M., Daneault, V., Martineau‐Dussault, M., Baril, A., Gagnon, K., Lafond, C., Gilbert, D., Thompson, C., Marchi, N. A., Lina, J., et al. (2023) · Frontiers in Neurology · doi:10.3389/fneur.2023.1215882 · Cited by 15
Li, Y., Li, T., Chen, T., Li, C., Yu, W., Xu, Y., Zeng, X., & Zheng, F. (2024) · Journal of Integrative Neuroscience · doi:10.31083/j.jin2305091 · Cited by 15
Hasegawa, T., Ichiba, M., Matsumoto, S., Kasanuki, K., Hatano, T., Fujishiro, H., Iseki, E., Hattori, N., Yamada, T., & Tabira, T. (2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2012-120022 · Cited by 13
Proenergetic effects of resveratrol in the murine neuronal cell line Neuro2a
Nguyen, N. T. Q., Ooi, L., Piller, S. C., & Münch, G. W. (2013) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201300145 · Cited by 13
Kondo, M., Tokuda, T., Itsukage, M., Kuriyama, N., Matsushima, S., Yamada, K., Nakanishi, H., Ishikawa, M., & Nakagawa, M. (2013) · The Neuroradiology Journal · doi:10.1177/197140091302600107 · Cited by 13
Ryu, W., Cohen, B. M., & Sonntag, K. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.697578 · Cited by 14
Correlation of brain amyloid with “aerobic glycolysis”: a question of assumptions?
Phelps, M. E., & Barrio, J. R. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1012684107 · Cited by 12
A whole‐brain functional connectivity model of Alzheimer's disease pathology
Prakash, R. S., McKenna, M. R., Gbadeyan, O., Shankar, A., Pugh, E., Teng, J., Andridge, R., Berry, A. S., & Scharre, D. W. (2024) · Alzheimer s & Dementia · doi:10.1002/alz.14349 · Cited by 12
Phosphoproteomic Profiling of Selenate-Treated Alzheimer's Disease Model Cells
Chen, P., Wang, L., Wang, Y., Li, S., Shen, L., Liu, Q., & Ni, J. (2014) · PLoS ONE · doi:10.1371/journal.pone.0113307 · Cited by 12
Luo, T., Tu, Y., Huang, S., Ma, Y., Wang, Q., Wang, Y., Wang, J., & Initiative, A. D. N. (2023) · European Journal of Neurology · doi:10.1111/ene.15868 · Cited by 13
ApoE: The link between Alzheimer’s-related glucose hypometabolism and Aβ deposition?
Patil, S. P., Ballard, R., Sanchez, S., Osborn, J., & Santangelo, D. (2012) · Medical Hypotheses · doi:10.1016/j.mehy.2012.01.015 · Cited by 13
Piquet, J., Toussay, X., Hepp, R., Lerchundi, R., Douce, J. L., Faivre, É., Guiot, E., Bonvento, G., & Cauli, B. (2018) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2018.00216 · Cited by 13
de Muniain, L. S., Escalada, P., Ramírez, M. J., & Solas, M. (2025) · Journal of Neurochemistry · doi:10.1111/jnc.70252 · Cited by 11
Wang, C., Ji, D., Su, X., Liu, F., Zhang, Y., Lu, Q., Cai, L., Wang, Y., Qin, W., Xing, G., et al. (2025) · The Journal of Prevention of Alzheimer s Disease · doi:10.1016/j.tjpad.2024.100031 · Cited by 10
Statistical mechanics of interacting metabolic networks
Fernández-de-Cossio-Díaz, J., & Mulet, R. (2020) · Physical review. E · doi:10.1103/physreve.101.042401 · Cited by 10
Persistent changes in extracellular lactate dynamics following synaptic potentiation
Bingul, D., Kalra, K., Murata, E. M., Belser, A., & Dash, M. B. (2020) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2020.107314 · Cited by 13
Li, K., Laird, A. R., Price, L. R., McKay, D., Blangero, J., Glahn, D. C., & Fox, P. T. (2016) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2016.00137 · Cited by 10
Weyts, K., Vernooij, M. W., Steketee, R. M. E., Valkema, R., & Smits, M. (2017) · Clinical Imaging · doi:10.1016/j.clinimag.2017.05.008 · Cited by 11
Synaptic signaling modeled by functional connectivity predicts metabolic demands of the human brain
Klug, S., Murgaš, M., Godbersen, G. M., Hacker, M., Lanzenberger, R. R., & Hahn, A. (2024) · NeuroImage · doi:10.1016/j.neuroimage.2024.120658 · Cited by 8
Carnosine supplementation improves cognitive outcomes in younger participants of the NEAT trial
O’Toole, T. E., Amraotkar, A. R., Gao, H. T., Sears, C. G., Rai, S. N., Basner, M., & Bhatnagar, A. (2025) · Neurotherapeutics · doi:10.1016/j.neurot.2025.e00541 · Cited by 9
Monitoring Acidification Preceding Aβ Deposition in Alzheimer's Disease
Zhu, G., Zhang, H., Xie, R., Younis, M. R., Fu, S., Wang, X., Liu, B., Li, K., Lui, S., & Wu, M. C. (2025) · Advanced Healthcare Materials · doi:10.1002/adhm.202404907 · Cited by 8
Beresford‐Webb, J., McAllister, C. J., Sleigh, A., Walpert, M., Holland, A. J., & Zaman, S. H. (2025) · Brain Sciences · doi:10.3390/brainsci15020130 · Cited by 10
Sobczak, A. M., Bohaterewicz, B., Ceglarek, A., Żyrkowska, A., Fąfrowicz, M., Słowik, A., Wnuk, M. A., Marona, M., Nowak, K., Żur‐Wyrozumska, K., et al. (2022) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2022.852981 · Cited by 8
Locus Coeruleus and Noradrenergic Pharmacology in Neurodegenerative Disease
Matt, R. A., Martin, R. S., Evans, A. K., Gever, J. R., Vargas, G. A., Shamloo, M., & Ford, A. P. D. W. (2023) · Handbook of experimental pharmacology · doi:10.1007/164_2023_677 · Cited by 11
Angleys, H., Jespersen, S. N., & Østergaard, L. (2016) · Frontiers in Computational Neuroscience · doi:10.3389/fncom.2016.00103 · Cited by 8
Reply to Biskup et al. and Tu et al.: Sex differences in metabolic brain aging
Goyal, M. S., Vlassenko, A. G., & Raichle, M. E. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1904673116 · Cited by 8
Self-citation
Metadata
- Authors
- Vlassenko, A. G., Vaishnavi, S. N., Couture, L., Sacco, D., Shannon, B. J., Mach, R. H., Morris, J. C., Raichle, M. E., & Mintun, M. A.
- Affiliations
- Washington University in St. Louis (US)
- Departments of aRadiology,
- Neurology,
- Corresponding author
- Mintun, Mark A.
- ORCID
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2010-09-13
- Volume
- 107
- Issue
- 41
- Pages
- 17763-17767
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC2955133
- OpenAlex
- W2137243283
- Cited by
- 404
- References
- 84
- Citations by year
- 2026: 20 · 2025: 21 · 2024: 15 · 2023: 21 · 2022: 26 · 2021: 22 · 2020: 24 · 2019: 20 · 2018: 28 · 2017: 41 · 2016: 20 · 2015: 23 · 2014: 28 · 2013: 33 · 2012: 28
- FWCI
- 20.41
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5p20mh077967-04, AG05681, AG003991)
- National Institute on Aging (P50AG005681, P01AG003991)
- National Institute of Mental Health (P20MH-077967)
- National Institute of Neurological Disorders and Stroke (F30NS057901, P30NS048056, P50NS006833)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Medical Imaging Techniques and Applications
- Keywords
- aerobic glycolysis, amyloid-beta deposition, Alzheimer's disease, default mode network, brain glucose metabolism, oxidative phosphorylation, spatial correlation, young adults, positron emission tomography
- MeSH terms
- Adult, Alzheimer Disease, Amyloid, Brain, Female, Glucose, Glycolysis, Humans, Male, Oxygen, Positron-Emission Tomography
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review